Here are just a few more Big Pharma deals. Note that they are mostly deals in the 100s of millions of dollars. Also note some were still in pre-clinical testing and one had yet to emerge from research phase.
Novartis/Astex in Phase I deal for 520 million 12/2005
Genentech/Piramed in Preclinical for 230 million 12/2005
Merck & Co/Agensys in Phase I 199 million with 17,5 million upfront 10/2005
Genentech/Curis in research phase 140 million 04/2005
Pharmion Methylgene in Phase I for 245 million with 25 million up front 02/2006
Novartis/Infinity in Preclinical for 370 million 03/2006
Medimmune/Infinity in Phase I for 430 million with 70 million up front 09/2006
Roche/Plexxicon in Preclinical for 660 million with 40 million up front 10/2006
Genentech/Exelixis in Preclinical for 40 million 01/2007
Kyowa/ArQules in Phase I for 123 million with 30 million up front 04/2007
Market Data 
Markets 
AI
